Lattulosio Pensa

Lactulose, the active ingredient in Lattulosio Pensa, is an osmotic laxative presented as an oral preparation for oral use. It is employed to relieve constipation and to manage hepatic encephalopathy by lowering intestinal ammonia levels in adult patients and is commonly prescribed in clinical settings. The drug works locally within the gastrointestinal tract without systemic absorption.

GNH USA supplies Lattulosio Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery to healthcare providers across multiple regions.

Lactulose acts as an osmotic laxative and ammonia‑lowering agent in the gastrointestinal tract.

- Constipation: softens stool and increases bowel frequency to relieve infrequent or difficult evacuation. - Prevention of hepatic encephalopathy: reduces intestinal ammonia production, helping to prevent neurocognitive deterioration in patients with chronic liver disease. - Treatment of hepatic encephalopathy: lowers systemic ammonia levels, improving mental status and reducing episodes of hepatic encephalopathy.

Lactulose may cause a range of adverse reactions, from mild gastrointestinal discomfort to rare serious events.

Common Side Effects: - Flatulence: increased intestinal gas production. - Abdominal cramping: intermittent stomach pain. - Diarrhea: loose stools that may lead to urgency. - Nausea: feeling of sickness. - Bloating: sensation of abdominal fullness. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium or potassium levels. - Dehydration: excessive fluid loss leading to weakness. - Allergic reaction: rash, itching, or swelling. - Hypernatremia: elevated blood sodium concentration. - Acute colitis: inflammation of the colon.

When prescribing lactulose, clinicians should consider several safety measures to minimize risks. - Dose adjustment in renal impairment: monitor renal function and reduce dose if needed. - Monitor electrolytes: check serum sodium and potassium during prolonged therapy. - Caution in diabetes: lactulose may affect blood glucose; observe glycemic control. - Avoid in intestinal obstruction: contraindicated when bowel blockage is present. - Use under medical supervision in children: pediatric dosing requires physician guidance. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Lactulose can interact with other medicines, altering its efficacy or increasing adverse effects.

Major Interactions (Avoid): - Antacids containing magnesium: may enhance osmotic effect and cause diarrhea. - Other laxatives: additive laxative effect leading to excessive stool loss. - Diuretics: increased risk of electrolyte disturbances when combined.

Moderate Interactions (Monitor Closely): - Antibiotics: may modify gut flora, affecting lactulose metabolism. - Metformin: concurrent use may increase risk of gastrointestinal upset. - Probiotics: potential alteration of colonic bacteria influencing lactulose conversion.